Back to Journals » Drug Design, Development and Therapy » Volume 10
RETRACTED ARTICLE: MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2
Authors Qin X, Wan Y, Wang S, Xue M
Received 25 July 2015
Accepted for publication 17 August 2015
Published 24 December 2015 Volume 2016:10 Pages 71—79
DOI https://doi.org/10.2147/DDDT.S93104
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Prof. Dr. Wei Duan
This paper has been retracted.
Qin X, Wan Y, Wang S, Xue M. Drug Des Devel Ther. 2016;10:71—79. https://doi.org/10.2147/DDDT.S93104
We, the Editors and Publisher of the journal Drug Design, Development and Therapy, have retracted the published article.
After publication, concerns have been raised by a third party in 2024 about the integrity of the data in Figure 3 of the article.
Further investigation conducted by the Journal and Publisher confirmed the following:
- Unexpected similarities within the individual figure panels in Figures 2D, 2E, 3B, 5D, and 5E.
- Unusual similarities between the image panels in Figures 2D and 2E.
When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.